People Are Already Taking This Unapproved New Weight-Loss Drug

Such endorsements abound online. Other reta boosters also flag its alleged ability to reduce cravings for drugs and alcohol. (Some clinical literature has suggested the potential of GLP-1-type drugs in the treatment of addiction, attributable to their ability to rewire dopamine signaling in the brain.) Less desirable side effects reported, in trials and anecdotally, include low energy, dizziness, cutaneous hyperesthesia (a form of extreme sensitivity to touch), and decreased libido.

Eli Lilly, the…